Trials / Completed
CompletedNCT05812417
A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010
An Open-label, Single-dose, Parallel-group Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This Study will evaluate the effects of renal function on pharmacokinetics and safety of DA-8010
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-8010 | DA-8010 5mg single dose administration |
Timeline
- Start date
- 2023-05-02
- Primary completion
- 2024-06-07
- Completion
- 2024-06-07
- First posted
- 2023-04-13
- Last updated
- 2024-06-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05812417. Inclusion in this directory is not an endorsement.